Skip to main content

Research Repository

Advanced Search

Efficient and scalable generation of human ventral midbrain astrocytes from human-induced pluripotent stem cells

Crompton, Lucy A.; McComish, Sarah F.; Stathakos, Petros; Cordero-Llana, Oscar; Lane, Jon D.; Caldwell, Maeve A.

Authors

Profile image of Lucy Crompton

Dr Lucy Crompton Lucy.Crompton@uwe.ac.uk
Senior Lecturer in Biomedical Sciences (Neuroscience)

Sarah F. McComish

Petros Stathakos

Oscar Cordero-Llana

Jon D. Lane

Maeve A. Caldwell



Abstract

In Parkinson's disease, progressive dysfunction and degeneration of dopamine neurons in the ventral midbrain cause life-changing symptoms. Neuronal degeneration has diverse causes in Parkinson's, including non-cell autonomous mechanisms mediated by astrocytes. Throughout the CNS, astrocytes are essential for neuronal survival and function, as they maintain metabolic homeostasis in the neural environment. Astrocytes interact with the immune cells of the CNS, microglia, to modulate neuroinflammation, which is observed from the earliest stages of Parkinson's, and has a direct impact on the progression of its pathology. In diseases with a chronic neuroinflammatory element, including Parkinson's, astrocytes acquire a neurotoxic phenotype, and thus enhance neurodegeneration. Consequently, astrocytes are a potential therapeutic target to slow or halt disease, but this will require a deeper understanding of their properties and roles in Parkinson's. Accurate models of human ventral midbrain astrocytes for in vitro study are therefore urgently required. We have developed a protocol to generate high purity cultures of ventral midbrain-specific astrocytes (vmAstros) from hiPSCs that can be used for Parkinson's research. vmAstros can be routinely produced from multiple hiPSC lines, and express specific astrocytic and ventral midbrain markers. This protocol is scalable, and thus suitable for high-throughput applications, including for drug screening. Crucially, the hiPSC derived-vmAstros demonstrate immunomodulatory characteristics typical of their in vivo counterparts, enabling mechanistic studies of neuroinflammatory signaling in Parkinson's.

Journal Article Type Article
Acceptance Date Jul 1, 2021
Online Publication Date Oct 2, 2021
Publication Date Oct 2, 2021
Deposit Date Apr 21, 2022
Journal Journal of Visualized Experiments
Electronic ISSN 1940-087X
Publisher Journal of Visualized Experiments
Peer Reviewed Peer Reviewed
Issue 176
Article Number e62095
DOI https://doi.org/10.3791/62095
Keywords stem cells, astrocytes, parkinson's, induced pluripotent
Public URL https://uwe-repository.worktribe.com/output/9378324